Product Name :
CEP-32496
Description:
Agerafenib, also known as RXDX-105, CEP-32496 and AC013773, is an orally available v-raf murine sarcoma viral oncogene homolog B1 (B-raf) serine/threonine protein kinase inhibitor with potential antineoplastic activity. CEP-32496 specifically and selectively inhibits the activity of the mutated form (V600E) of B-raf kinase. This inhibits the activation of the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway and may result in a decrease in the proliferation of tumor cells expressing the mutated B-raf gene.
CAS:
1188910-76-0
Molecular Weight:
517.46
Formula:
C24H22F3N5O5
Chemical Name:
1-{3-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}-3-[5-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-3-yl]urea
Smiles :
CC(C)(C1=CC(NC(=O)NC2=CC(=CC=C2)OC2=NC=NC3=CC(OC)=C(C=C32)OC)=NO1)C(F)(F)F
InChiKey:
DKNUPRMJNUQNHR-UHFFFAOYSA-N
InChi :
InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥360 days if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Agerafenib, also known as RXDX-105, CEP-32496 and AC013773, is an orally available v-raf murine sarcoma viral oncogene homolog B1 (B-raf) serine/threonine protein kinase inhibitor with potential antineoplastic activity. CEP-32496 specifically and selectively inhibits the activity of the mutated form (V600E) of B-raf kinase. This inhibits the activation of the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-related kinase (ERK) signaling pathway and may result in a decrease in the proliferation of tumor cells expressing the mutated B-raf gene.|Product information|CAS Number: 1188910-76-0|Molecular Weight: 517.46|Formula: C24H22F3N5O5|Chemical Name: 1-{3-[(6,7-dimethoxyquinazolin-4-yl)oxy]phenyl}-3-[5-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-3-yl]urea|Smiles: CC(C)(C1=CC(NC(=O)NC2=CC(=CC=C2)OC2=NC=NC3=CC(OC)=C(C=C32)OC)=NO1)C(F)(F)F|InChiKey: DKNUPRMJNUQNHR-UHFFFAOYSA-N|InChi: InChI=1S/C24H22F3N5O5/c1-23(2,24(25,26)27)19-11-20(32-37-19)31-22(33)30-13-6-5-7-14(8-13)36-21-15-9-17(34-3)18(35-4)10-16(15)28-12-29-21/h5-12H,1-4H3,(H2,30,31,32,33)|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Xevinapant} web|{Xevinapant} Apoptosis|{Xevinapant} Protocol|{Xevinapant} Data Sheet|{Xevinapant} custom synthesis|{Xevinapant} Cancer} |Shelf Life: ≥360 days if stored properly.{{Polydatin} MedChemExpress|{Polydatin} Apoptosis|{Polydatin} Biological Activity|{Polydatin} Formula|{Polydatin} supplier|{Polydatin} Autophagy} |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:35991869 |Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|